Target intelligence / Profile preview

Protocadherin alpha-12 (PCDHA12)

Target
PCDHA12
Molecular classification
Cadherin superfamily, Clustered protocadherin, Cell adhesion molecule
01

Overview

Protocadherin alpha-12 (PCDHA12) is a member of the protocadherin alpha gene cluster, which belongs to the cadherin superfamily of neural cell adhesion molecules. These proteins are integral plasma membrane components, most likely playing critical roles in establishing and maintaining specific cell-cell connections in the brain, especially in neural circuit development. The gene exhibits an unusual genomic organization similar to immune receptor gene clusters, encoding extracellular cadherin domains that mediate homophilic (isoform-specific) and heterophilic cell–cell recognition in the nervous system. Mutations or alteration in PCDHA12 have been associated with autism spectrum disorder and potentially other neurodevelopmental conditions. There is no evidence from available data to classify PCDHA12 as a direct therapeutic target (such as a druggable receptor or enzyme), nor are there any known drugs, biomarkers, or safety issues directly linked to this molecule, though it may be relevant as a biomarker or for genetic research in neurodevelopmental diseases[1][3][2][4][5].

Other names
Protocadherin alpha-12PCDHA12PCDH-alpha-12PCDH-ALPHA12KIAA0345-like 2PCDAC_HUMAN
02

Biological functions

Cell-cell adhesionNeuronal circuit assemblyCalcium ion bindingEstablishment and maintenance of specific neural connections
03

Disease associations

Autism spectrum disorderNeurodevelopmental disorders

Beyond the preview

Go deeper on Protocadherin alpha-12 (PCDHA12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin alpha-12 (PCDHA12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call